More Infections Tied to Bausch Contact Cleaner
June 23, 2006 17:17

"An update yesterday from government health authorities on the outbreak of a potentially blinding fungal infection among contact lens users showed a sharp increase in the number of cases involving users of the ReNu brand of lens cleaners made at Bausch & Lomb's Greenville, S.C., factory. The Centers for Disease Control said that it now had 106 confirmed cases of infection with the Fusarium fungus, up 4 from last Friday. But it said that the number linked to ReNu products had jumped to 87, from 54, over the same period. The infections cause severe inflammation of the cornea. The majority of the 93 confirmed infections linked to lens users - 63 percent in yesterday's report - continue to involve Bausch ReNu with MoistureLoc, a line that the company recalled from stores last month."

Barnaby J. Feder, New York Times, 5/10/06

Anapol Schwartz Announces that Michael Monheit, Esq. has Joined the Firm as Managing Attorney for all Internet Marketing Activities
June 23, 2006 17:48

Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C. announces that Michael H. Monheit, Esq. has joined the firm as managing attorney for all Internet marketing activities. He will be a member of the firm's marketing committee and computers committee.Philadelphia,... (Read Article)

Why are ReNu Lawsuits filed? What are the basic allegations?
June 24, 2006 17:25

ReNu Lawsuits are filed to recover damages for Plaintiff's personal injuries arising out of the Defendant Bausch & Lomb's failures in the design, manufacture and sale of a contact lens care product known as Baush & Lomb ReNu with MoistureLoc Multi-Purpose Solution.... (Read Article)

What is ReNu with MultiLoc. Is it FDA regulated?
June 25, 2006 17:31

ReNu is a medical device, regulated by the FDA. The trade device name for the product in question is Bausch & Lomb ReNu with MoistureLoc multi-Purpose Solution, Regulation number 21 CFR 886.5928, Regulatory Name, soft (hydrophilic) contact Lens Care Product,... (Read Article)